<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout</h2>
    <div class="badge">2025-09-15T20:08:46+00:00</div>
    <ul>
      <li>Monopar Therapeutics unveiled promising results Monday from three key studies, leading the top 1% biotech stock to break out of a cup base.</li>
<li>Oops, something went wrong Monopar Therapeutics unveiled promising results Monday from three key studies, leading the top 1% biotech stock to break out of a cup base.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout\n• Monopar Therapeutics unveiled promising results Monday from three key studies, leading the top 1% biotech stock to break out of a cup base.\n• Oops, something went wrong Monopar Therapeutics unveiled promising results Monday from three key studies, leading the top 1% biotech stock to break out of a cup base." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/m/dd13b6bf-58fb-3ec6-8899-63efa6a71245/why-monopar-therapeutics%2C-a.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>